前列腺切除术后失败的预后因素。
Prognostic factors for failure after prostatectomy.
机构信息
1. Departments of Radiation Oncology, Radiology and Urology, UT Health Science Center San Antonio, San Antonio, TX 78229, USA.
出版信息
J Cancer. 2010 Dec 7;2:1-19.
Abstract
Several randomized studies have been completed in prostate cancer that show a benefit to immediate postoperative treatment in patients undergoing prostatectomy. In one of the studies, there was even a survival advantage. In spite of those positive findings, there has been some reluctance to uniformly offer adjuvant treatment to patients. The perception is that the risk is not really high enough to warrant the risk of toxicity that comes with treatment. There are clearly factors that can help predict who is at the highest risk. Our purpose is to review those factors and identify patients that have a high enough risk justifying immediate treatment.
摘要
几项针对前列腺癌的随机研究表明，前列腺切除术患者术后立即进行治疗有获益。其中一项研究甚至显示出生存优势。尽管有这些积极的发现，但人们还是不愿意为所有患者提供辅助治疗。人们认为风险还不够高，无法承受治疗带来的毒性风险。显然，有一些因素可以帮助预测哪些患者的风险最高。我们的目的是回顾这些因素，并确定那些风险足够高的患者需要立即进行治疗。
相似文献
1
Prognostic factors for failure after prostatectomy.
J Cancer. 2010 Dec 7;2:1-19.
2
Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy.
Urology. 1996 Feb;47(2):232-5. doi: 10.1016/s0090-4295(99)80422-1.
3
Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy.
Strahlenther Onkol. 2019 Feb;195(2):131-144. doi: 10.1007/s00066-018-1359-2. Epub 2018 Sep 4.
4
Adjuvant external radiation therapy following radical prostatectomy for node-negative prostate cancer.
Curr Opin Urol. 2003 Mar;13(2):117-22. doi: 10.1097/00042307-200303000-00006.
5
Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease.
J Urol. 2012 Jul;188(1):84-90. doi: 10.1016/j.juro.2012.02.2572. Epub 2012 May 12.
6
Adjuvant and salvage treatment options for patients with high-risk prostate cancer treated with radical prostatectomy.
Prostate Cancer Prostatic Dis. 2007;10(2):119-26. doi: 10.1038/sj.pcan.4500947. Epub 2007 Feb 20.
7
Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review.
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):972-9. doi: 10.1016/j.ijrobp.2008.07.026.
8
Adjuvant therapy for prostate cancer patients at high risk of recurrence following radical prostatectomy.
Eur Urol. 1997;32 Suppl 3:65-9.
9
Adjuvant radiotherapy for high-risk patients following radical prostatectomy.
Urol Oncol. 2007 Nov-Dec;25(6):515-9. doi: 10.1016/j.urolonc.2007.05.022.
10
Radiation therapy after radical prostatectomy: a review of the issues and options.
Semin Radiat Oncol. 2003 Apr;13(2):130-40. doi: 10.1053/srao.2003.50010.
引用本文的文献
1
Prostate Cancer Morphologies: Cribriform Pattern and Intraductal Carcinoma Relations to Adverse Pathological and Clinical Outcomes-Systematic Review and Meta-Analysis.
Cancers (Basel). 2023 Feb 21;15(5):1372. doi: 10.3390/cancers15051372.
2
Impact of positive surgical margin on biochemical recurrence in localized prostate cancer.
Prostate Int. 2021 Sep;9(3):151-156. doi: 10.1016/j.prnil.2020.12.004. Epub 2021 Mar 9.
3
Receptor-Targeted Fluorescence-Guided Surgery With Low Molecular Weight Agents.
Front Oncol. 2021 Jun 30;11:674083. doi: 10.3389/fonc.2021.674083. eCollection 2021.
4
Prostate cancer: a presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy.
Asian J Androl. 2021 Sep-Oct;23(5):516-519. doi: 10.4103/aja.aja_9_21.
5
Effect of Palmitic Acid on Exosome-Mediated Secretion and Invasive Motility in Prostate Cancer Cells.
Molecules. 2020 Jun 12;25(12):2722. doi: 10.3390/molecules25122722.
6
Long-Term Follow-Up after Prostatectomy for Prostate Cancer and the Need for Active Monitoring.
Prostate Cancer. 2020 Mar 10;2020:7196189. doi: 10.1155/2020/7196189. eCollection 2020.
7
The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis.
Radiat Oncol. 2019 Nov 9;14(1):197. doi: 10.1186/s13014-019-1384-z.
8
Elevated Expression Levels of PC3-Secreted Microprotein (PSMP) in Prostate Cancer Associated With Increased Xenograft Growth and Modification of Immune-Related Microenvironment.
Front Oncol. 2019 Aug 28;9:724. doi: 10.3389/fonc.2019.00724. eCollection 2019.
9
Cytokines expression levels from tissue, plasma or serum as promising clinical biomarkers in adenocarcinoma of the prostate: a systematic review of recent findings.
Ann Transl Med. 2019 Jun;7(11):245. doi: 10.21037/atm.2019.05.31.
10
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance.
BJU Int. 2019 May;123(5):846-853. doi: 10.1111/bju.14554. Epub 2018 Oct 15.
本文引用的文献
1
Preoperative prostate specific antigen doubling time is not a useful predictor of biochemical progression after radical prostatectomy.
J Urol. 2010 May;183(5):1816-21. doi: 10.1016/j.juro.2010.01.011. Epub 2010 Mar 29.
2
Salvage or adjuvant radiation therapy: counseling patients on the benefits.
J Natl Compr Canc Netw. 2010 Feb;8(2):228-37. doi: 10.6004/jnccn.2010.0015.
3
Time trends and local variation in primary treatment of localized prostate cancer.
J Clin Oncol. 2010 Mar 1;28(7):1117-23. doi: 10.1200/JCO.2009.26.0133. Epub 2010 Feb 1.
4
The significance of a positive bladder neck margin after radical prostatectomy: the American Joint Committee on Cancer Pathological Stage T4 designation is not warranted.
J Urol. 2010 Jan;183(1):151-7. doi: 10.1016/j.juro.2009.08.138.
5
Impact of positive surgical margins after radical prostatectomy differs by disease risk group.
J Urol. 2010 Jan;183(1):145-50. doi: 10.1016/j.juro.2009.08.132.
6
Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy.
BJU Int. 2010 Jun;105(12):1654-9. doi: 10.1111/j.1464-410X.2009.09060.x. Epub 2009 Nov 13.
7
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.
J Urol. 2009 Oct;182(4):1357-63. doi: 10.1016/j.juro.2009.06.046. Epub 2009 Aug 14.
8
Cancer statistics, 2009.
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
9
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
J Clin Oncol. 2009 Jun 20;27(18):2924-30. doi: 10.1200/JCO.2008.18.9563. Epub 2009 May 11.
10
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.
J Urol. 2009 Mar;181(3):956-62. doi: 10.1016/j.juro.2008.11.032. Epub 2009 Jan 23.
Zotero 插件